On August 26, 2016, The US Food and Drug Administration (USFDA) recommended universal Zika virus testing of all donated blood. Previously, the FDA recommended Zika virus testing only in blood donations in areas with active Zika virus transmission. It recommends that all testing be performed with a blood screening test authorized for use by the FDA under an investigational new drug (IND) application.
If your company manufactures a biological product using blood or blood components that needs a laboratory for virus testing, Submit Laboratory Test Request
To read the entire US FDA Press Release, visit http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm518218.htm